Skip to main content
Clinical Trials/IRCT20190911044744N4
IRCT20190911044744N4
Completed
Phase 3

Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary Angiography: A randomized controlled Trial

Yazd University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Contrast induced nephropathy in following coronary angiography.
Sponsor
Yazd University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 18 years and older
  • Hospitalized in Afshar Yazd Hospital, who is undergoing coronary angioplasty as a non\-emergency.
  • not receiving nephrotoxic drugs.
  • not taking curcumin containing drugs in the past one month and no history of allergic reaction after taking oral curcumin
  • Hospitalization in the cardiac intensive care unit for 2 days Informed consent of the patient himself or his legal guar
  • Informed consent of the patient himself or his legal guardian.

Exclusion Criteria

  • Pregnant or lactating women
  • Allergy to curcumin
  • Receiving nephrotoxic drugs

Outcomes

Primary Outcomes

Not specified

Similar Trials